Published:
American Journal of Nephrology
Date:
Abstract:
People with diabetes and kidney disease have a high risk of cardiovascular
events and progression of kidney disease. Sodium glucose co-transporter 2
inhibitors lower plasma glucose by reducing the uptake of filtered glucose
in the kidney tubule, leading to increased urinary glucose excretion.